
| ASSET | QUARTER | % RETURN |
|---|---|---|
Aehr Test Systems (AEHR) | Q3 2021 | 391.01% |
Fulcrum Therapeutics (FULC) | Q3 2021 | 172.3% |
Upstart Holdings (UPST) | Q3 2021 | 151.14% |
TROOPS (TROO) | Q3 2021 | 130.61% |
Ramaco Resources (METC) | Q3 2021 | 124.63% |
Invivyd (IVVD) | Q3 2021 | 101.14% |
SandRidge Energy (SD) | Q3 2021 | 98.93% |
Standard Lithium (SLI) | Q3 2021 | 96.85% |
Hut 8 Corp Common Stock (HUT) | Q3 2021 | 95.35% |
Taskus (TASK) | Q3 2021 | 94.06% |
Alpha Metallurgical Resources (AMR) | Q3 2021 | 92.17% |
Dynavax Technologies (DVAX) | Q3 2021 | 92.1% |
Regencell Bioscience (RGC) | Q3 2021 | 88.76% |
Grid Dynamics (GDYN) | Q3 2021 | 88.64% |
Peabody Energy (BTU) | Q3 2021 | 83.73% |
Cytokinetics (CYTK) | Q3 2021 | 79.96% |
DeFi Technologies (DEFT) | Q3 2021 | 79.17% |
Corvus Pharmaceuticals (CRVS) | Q3 2021 | 77.94% |
Affirm (AFRM) | Q3 2021 | 77.81% |
Aurinia Pharmaceuticals (AUPH) | Q3 2021 | 71.42% |
InMode (INMD) | Q3 2021 | 68.36% |
Lsb Industries (LXU) | Q3 2021 | 67.38% |
Travere Therapeutics (TVTX) | Q3 2021 | 66.55% |
Asana (ASAN) | Q3 2021 | 64.36% |
Moderna (MRNA) | Q3 2021 | 62.87% |